Publication at First Faculty of Medicine |
2010
Abstract
Despite the undeniable progress in first-line treatment, a significant proportion of patients with lymphoproliferative disease still relapse. Transplant strategy is one of the most effective options for such patients.
Autologous stem cell transplantation has for many years been the standard position in the treatment of chemosensitive relapse of diffuse large B cell lymphoma, Hodgkin's lymphoma and follicular lymphoma. Recently, autologous stem cell transplantation has had significant importance in first-line therapy of some T-cell lymphoma and mantle cell lymphoma as well.